Isabelle Mahé on Delphi Consensus on Aspects Relating to the Antithrombotic Therapy for Cancer Patients
Isabelle Mahé, Head of Internal Medicine, Louis Mourier Hospital, APHP, Paris Cité University, reposted from SERENITY on LinkedIn:
”A two-round Delphi process was used to achieve consensus on aspects relating to the antithrombotic therapy deprescribing discussions and process in end-of-life cancer patients across Europe and different specialities.
The perspective is to support informed decision-making, reduce complications, and improve quality of life in palliative care patients.”
Quoting SERENITY‘s post:
”Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
For the DELPHI Serenity Group
Isabelle Mahé Anette Arbjerg Højen
Prof.Dr.Stavros Konstantinides
Sebastian Szmit
Denise Abbel
Laurent Bertoletti
Adrian Edwards
Jacobijn Gussekloo
Johan Langendoen
Simon Mooijaart
Stella Trompet
Erik Klok
Professor Simon Noble
Camille Couffignal”
Read the full article here.
Article: Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study
Authors: For the DELPHI Serenity Group – Skerdi Haviarie, Nassima Si Mohammed, Anette Arbjerg Højeng, Carme Fonth, Stavros Konstantinides, Marieke Kruip, Luigi Maiorana, Sebastian Szmit, Denise Abel, Laurent Bertoletti, Adrian Edwards, Michelle Edwards, Alessandra Gaval, Jacobijn Gussekloo, Miriam Johnson, Rashmi Kumar, Johan Langendoen, Kate Lifford, Simon Mooijaart, Mark Pearson, Johanneke Portielje, Kathy Seddon, Stella Trompet, Hélène Helfer, Frederikus Klok, Simon Noble, Camille Couffignal
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging